Lin P, Jones D, Dorfman DM, et al. Precursor B⁃cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement[J]. Am J Surg Pathol, 2000, 24(11): 1480⁃1490.
[2]
Lee WJ, Moon HR, Won CH, et al. Precursor B⁃ or T⁃lymphoblastic lymphoma presenting with cutaneous involvement: a series of 13 cases including 7 cases of cutaneous T⁃lymphoblastic lymphoma[J]. J Am Acad Dermatol, 2014, 70(2): 318⁃325. DOI: 10.1016/j.jaad.2013.10.020.
[3]
Ginoux E, Julia F, Balme B, et al. T⁃lymphoblastic lymphoma with cutaneous involvement[J]. World J Clin Cases, 2015, 3(8): 727⁃731. DOI: 10.12998/wjcc.v3.i8.727.
[4]
Torlakovic E, Torlakovic G, Nguyen PL, et al. The value of anti⁃pax⁃5 immunostaining in routinely fixed and paraffin⁃embedded sections: a novel pan pre⁃B and B⁃cell marker[J]. Am J Surg Pathol, 2002, 26(10): 1343⁃1350.
Goldberg JM, Silverman LB, Levy DE, et al. Childhood T⁃cell acute lymphoblastic leukemia: the Dana⁃Farber Cancer Institute acute lymphoblastic leukemia consortium experience[J]. J Clin Oncol, 2003, 21(19): 3616⁃3622. DOI: 10.1200/JCO.2003.10.116.
[8]
Bassan R, Maino E, Cortelazzo S. Lymphoblastic lymphoma: an updated review on biology, diagnosis, and treatment[J]. Eur J Haematol, 2016, 96(5): 447⁃460. DOI: 10.1111/ejh.12722.